Hopp til hovedinnhold
Genital herpesinfeksjon kan ha typiske symptomer som at de ytre kjønnsorganene blir røde, hovne og ømme, og det dannes smertefulle blemmer.
Genital herpesinfeksjon kan ha typiske symptomer som at de ytre kjønnsorganene blir røde, hovne og ømme, og det dannes smertefulle blemmer.

Genital herpesinfeksjon

Genital herpes er en infeksjon i underlivet med herpes simplex virus (HSV). Første utbrudd kommer oftest få dager til uker etter smitte, senere kan infeksjonen komme tilbake gjentatte ganger, men med langt mindre plager.

Sist revidert:
QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/infeksjoner/kjonnssykdommer/herpes-genitalis/ 

Hva er genital herpesinfeksjon?

Årsak

Diagnosen

Behandling

Smitte

Prognose

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Herpes genitalis hos kvinner. Referanselisten for dette dokumentet vises nedenfor.

  1. Folkehelseinstituttet. Herpes simplexvirus-infeksjoner - veileder for helsepersonell. Smittevernveilederen. Sist oppdatert 17.04.2019. Siden lest 01.12.2022
  2. Bernstein DI, Bellamy AR, Hook EW III, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3):344–351.
  3. Groves MJ. Genital herpes: a review. Am Fam Physician. 2016 Jun 1;93(11):928-934.
  4. Hartgill U, Peterson H, Rimstad L. Vulvovaginale infeksjoner. Veileder i generell gynekologi. Norsk gynekologisk forening, 2015. legeforeningen.no 
  5. Rygh A, Kvalvik SA, Moksnes LR, Spydslaug A. Norsk gynekologisk forening. Gential herpes. Veileder i gynekologi 2021. Siden lest 12.12.2022 www.legeforeningen.no 
  6. Tata S, Johnston C, Huang ML, et al. Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa. J Infect Dis. 2010;201(4):499–504.
  7. Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342: 844-50. DOI: 10.1056/NEJM200003233421203 DOI 
  8. Tronstein E, Johnston C, Huang M-L, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011; 305: 1441-9. Journal of the American Medical Association 
  9. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341: 1432 - 8. New England Journal of Medicine 
  10. Johnston C, Magaret A, Son H, et al. Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection. JAMA 2022. pmid:36272098 PubMed 
  11. Donovan B. Sexually transmissible infections other than HIV. Lancet 2004; 363: 545-56. PubMed 
  12. Lautenschlager S, Eichmann A. The heterogeneous clinical spectrum of genital herpes. Dermatology 2001; 202: 211-9. PMID: 11385226 PubMed 
  13. Findal G, Nodenes K, Kro GAB, Barlinn R. Genital herpes i Veileder i fødselshjelp. Norsk gynekologisk forening 2020. Siden lest 12.12.2022 www.legeforeningen.no 
  14. Wald A, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003;188(9):1345–1351.
  15. Nilsen A. Systemisk antiviral behandling ved herpes genitalis. Tidsskr Nor Lægeforen 2002; 122: 2805-6. PubMed 
  16. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al, for the valacyclovir HSV transmission study group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350: 11-20. New England Journal of Medicine 
  17. Johnston C, Saracino M, Kuntz S, et al. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet 2012; doi:10.1016/S0140-6736(11)61750-9. DOI 
  18. Skiveren J, Bermark S, et al.: Klinisk retningslinje for rensning af akutte og kroniske sår: Sæbe, skyllevæsker og skylletryk. Sist revidert 31.07.2017. Center for kliniske retningslinjer, Aalborg Universitet. www.cfkr.dk 
  19. Kimberlin DW, Rouse DJ. Genital herpes. N Engl J Med 2004; 350: 1970-7. PubMed 
  20. Le Cleach L, Trinquart L, Do G, et al. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev. 2014 8:CD009036. doi: 10.1002/14651858.CD009036.pub2. DOI 
  21. Drake S, Taylor S, Brown D, Pillay D. Improving the care of patients with genital herpes. BMJ 2000; 321:619-23. British Medical Journal 
  22. Cowan FM, Pascoe SJ, Barlow KL, et al. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers. Sex Transm Infect 2008; 84: 548-53. PubMed 
  23. Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012; 366: 34-43. New England Journal of Medicine 
  24. Dunphy K. Herpes genitalis and the philosopher's stance. J Med Ethics. 2014;40(12):793–797.
  25. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83. PubMed 
  26. Corey L. Synergistic copathogens—HIV-1 and HSV-2. N Engl J Med. 2007;356(8):854–856.
  27. Centers for Disease Control and Prevention. 2015 sexually transmitted diseases treatment guidelines: genital HSV infections.. Accessed March 1, 2016. www.cdc.gov 
  28. Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm Infect. 2002;78(3):160–165.
  29. Bradley H, et al. Seroprevalence of herpes simplex virus types 1 and 2—United States, 1999–2010. J Infect Dis. 2014;209(3):325–333.
  30. Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database of Systematic Reviews 2008; 1: CD004946. Cochrane (DOI) 
  31. Pasternak B, Hviid A, . Use of acyclovir, valacyklivir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010; 304: 859-66. Journal of the American Medical Association 
  32. Stephenson-Famy A, Gardella C. Herpes simplex virus infection during pregnancy. Obstet Gynecol Clin North Am. 2014;41(4):601–614.